Oklo
OKLO
$40.57
+1.07%
Oklo Inc. is a developer of advanced fission power plants, focusing on the commercialization of its liquid metal fast reactor technology through the Aurora powerhouse product line, which is designed to produce up to 15 megawatts of electricity using both recycled and fresh nuclear fuel. The company also aims to provide used nuclear fuel recycling services to the U.S. market, positioning itself as a key player in the emerging small modular reactor (SMR) and nuclear energy sector. Oklo's distinct competitive identity lies in its innovative fast reactor design and its ability to secure high-profile partnerships, such as the recent deal with Meta to deploy a 1.2-gigawatt reactor in Ohio, which has brought significant attention to the stock. The current investor narrative is centered on the company's potential to capitalize on the growing demand for clean, reliable energy from AI data centers and government initiatives like Project Prometheus, while also grappling with concerns about valuation, dilution, and the long timeline to commercialization.…
OKLO
Oklo
$40.57
Related headlines
Investment Opinion: Should I buy OKLO Today?
Based on the analysis, Oklo is rated a Hold, as the potential for significant upside is offset by extreme risks and lack of fundamental support. The average analyst target of $79.875 implies a 99% upside, but the wide range (low $14, high $130) reflects high uncertainty. The stock is suitable only for speculative investors with a high risk tolerance and a long-term horizon.
Sign up to view all
OKLO 12-Month Price Forecast
The AI assessment is neutral, reflecting the balance between Oklo's transformative potential and its current lack of financial fundamentals. The company has secured high-profile partnerships and government support, which could lead to significant long-term value creation. However, the extreme valuation and negative cash flow make the stock highly speculative. The stance would upgrade to bullish if the company announces its first revenue contract or achieves a major regulatory milestone, providing tangible evidence of progress. Conversely, it would downgrade to bearish if the company faces a significant setback, such as a failed regulatory review or a major partner withdrawal, which would undermine the investment thesis.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Oklo's 12-month outlook, with a consensus price target around $79.88 and implied upside of +96.9% versus the current price.
Average Target
$79.88
0 analysts
Implied Upside
+96.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$14 - $130
Analyst target range
Oklo is covered by 20 analysts, with a consensus recommendation that is not explicitly stated (likely a mix of Buy and Neutral ratings), and the average target price is $79.875, implying an upside of approximately 99% from the current price of $40.14. The target range is wide, from a low of $14.00 to a high of $130.00, indicating significant uncertainty about the company's future prospects. The high target assumes successful commercialization and substantial revenue growth, while the low target reflects risks such as regulatory hurdles, competition, and potential dilution. Recent ratings from firms like Wedbush (Outperform) and Cantor Fitzgerald (Overweight) suggest a bullish tilt, but the presence of Neutral ratings from UBS and Goldman Sachs indicates that some analysts are cautious about the stock's valuation and execution risks.
Bulls vs Bears: OKLO Investment Factors
Oklo presents a classic high-risk, high-reward speculative investment. The bull case rests on transformative partnerships like Meta and government backing through Project Prometheus, which could position the company as a leader in the SMR space. However, the bear case is equally compelling: zero revenue, widening losses, extreme valuation, and a stock in a steep downtrend. Currently, the bearish evidence is stronger due to the lack of financial fundamentals and the stock's poor price performance, but the potential upside from successful commercialization is enormous. The key tension is whether Oklo can execute its ambitious timeline and secure regulatory approvals before cash burn forces dilutive financing or a strategic setback.
Bullish
- Meta Deal Validates Technology: Oklo's partnership with Meta to deploy a 1.2-gigawatt reactor in Ohio is a major endorsement from a tech giant, signaling confidence in Oklo's fast reactor technology. This deal provides a credible path to future revenue and could attract additional customers, underpinning the stock's long-term potential.
- Government Support via Project Prometheus: Oklo was selected as a key participant in the Trump administration's Project Prometheus, alongside X-Energy and Standard Nuclear, while competitor NuScale was excluded. This government backing enhances Oklo's credibility and access to federal resources, potentially accelerating regulatory approvals and funding.
- Strong Balance Sheet with No Debt: Oklo has a debt-to-equity ratio of 0.00098, indicating virtually no debt, and a current ratio of 49.08, reflecting ample liquidity to fund operations. This financial stability reduces bankruptcy risk and provides a runway to execute its development plans without immediate financing pressure.
- Analyst Targets Imply Significant Upside: The average analyst target price is $79.875, representing a 99% upside from the current price of $40.14. Even the low target of $14.00 is below current levels, but the high target of $130.00 suggests potential for a 224% gain if the company executes successfully, reflecting a favorable risk-reward for speculative investors.
Bearish
- Pre-Revenue with Widening Losses: Oklo has zero revenue, and its net loss widened to -$33.06 million in Q1 2026 from -$9.81 million in Q1 2025, a 237% increase. The trailing twelve-month free cash flow is -$153.48 million, indicating significant cash burn with no near-term revenue visibility, which could lead to dilution or financing needs.
- Extreme Valuation with No Earnings: With a market cap of $10.5 billion and zero revenue, the EV/Sales ratio is 4504.24, an astronomical premium. The trailing PE is -99.67 and forward PE is -39.97, both negative, meaning investors are pricing in massive future growth that may not materialize for years, leaving little room for error.
- Stock in Severe Downtrend: OKLO's price has fallen 48.47% over the past year, and it is down 39.98% over the last three months, trading near its 52-week low of $36.61. The stock's beta of 1.201 amplifies market volatility, and the negative momentum suggests persistent selling pressure, which could continue if sentiment remains bearish.
- Dilution Risk from Share Issuance: Shares outstanding increased from 138.1 million in Q1 2025 to 170.3 million in Q1 2026, a 23% rise, reflecting dilution from equity raises. This trend is likely to continue given the cash burn, potentially pressuring the stock price and reducing per-share value for existing shareholders.
OKLO Technical Analysis
Oklo's stock is in a pronounced downtrend over the past year, with a 1-year price change of -48.47%, and the current price of $40.14 sits near the lower end of its 52-week range, at approximately 20.7% of the range (calculated as (40.14 - 36.61) / (193.84 - 36.61)). This positioning near the 52-week low of $36.61 suggests that the stock is trading at levels that may reflect pessimism or a potential value opportunity, but the sustained decline indicates that negative momentum has been dominant. The stock's beta of 1.201 indicates it is about 20% more volatile than the market, amplifying both upside and downside moves.
Beta
1.20
1.20x market volatility
Max Drawdown
-78.8%
Largest decline past year
52-Week Range
$37-$194
Price range past year
Annual Return
-44.9%
Cumulative gain past year
| Period | OKLO Return | S&P 500 |
|---|---|---|
| 1m | +4.5% | +2.7% |
| 3m | -44.8% | +1.0% |
| 6m | -38.2% | +12.0% |
| 1y | -44.9% | +18.9% |
| ytd | -47.9% | +12.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OKLO Fundamental Analysis
Oklo is a pre-revenue company, with zero revenue reported in the most recent quarter (Q1 2026) and all prior quarters, reflecting its early-stage development status. The company's net loss widened to -$33.06 million in Q1 2026 from -$9.81 million in Q1 2025, and the trailing twelve-month free cash flow is -$153.48 million, indicating that the company is burning cash as it invests in R&D and regulatory processes. The lack of revenue means that growth metrics are not applicable, and the investment case relies on future commercialization milestones, such as the Meta deal and regulatory approvals, rather than current financial performance.
Quarterly Revenue
$0.0B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-153481000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OKLO Overvalued?
Given that Oklo has negative net income and EBITDA, the most appropriate valuation metric is the price-to-sales (PS) ratio, but since the company has zero revenue, the PS ratio is undefined (reported as 0). Therefore, we must rely on alternative metrics such as EV/Sales, which is 4504.24, reflecting an extreme valuation relative to any potential future sales. The trailing PE is -99.67 and forward PE is -39.97, both negative due to losses, and the PEG ratio is -2.78, indicating that the market is pricing in significant future growth despite current unprofitability. Compared to the industry average for independent power producers, Oklo's valuation is at a massive premium, but this is typical for a speculative growth company with no revenue, and the premium is justified only if the company successfully executes its ambitious plans.
PE
-99.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-88.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financially, Oklo is a pre-revenue company with no income, and its net loss expanded to -$33.06 million in Q1 2026, up from -$9.81 million a year earlier. The company's operating expenses, particularly R&D, have grown significantly, with R&D spending at $27.05 million in Q1 2026 versus $7.85 million in Q1 2025, indicating aggressive investment but also escalating cash burn. With a free cash flow of -$153.48 million over the trailing twelve months, Oklo will need to raise capital, likely through equity issuance, which could dilute shareholders. However, the company's strong balance sheet, with a current ratio of 49.08 and negligible debt, provides a cushion, but the lack of revenue means there is no margin for error in cost management.
FAQ
The key risks include: 1) Financial risk: zero revenue and a net loss of -$33.06 million in Q1 2026, with a free cash flow of -$153.48 million, leading to potential dilution. 2) Regulatory risk: the NRC approval process for advanced reactors is uncertain and could be delayed, jeopardizing the Meta deal. 3) Competitive risk: other SMR developers like NuScale and X-Energy are vying for market share, and NuScale's exclusion from Project Prometheus shows how quickly government support can shift. 4) Market risk: the stock's beta of 1.201 amplifies volatility, and it has already fallen 48.47% over the past year. The most severe risk is a worst-case scenario where the stock could lose up to 79% of its value, as seen in its max drawdown.
Over the next 12 months, the bull case (25% probability) targets $80-$130, driven by regulatory approvals and new partnerships. The base case (50% probability) targets $50-$80, assuming steady progress without major setbacks. The bear case (25% probability) targets $14-$40, if regulatory or financial issues arise. The most likely scenario is the base case, with the stock potentially recovering to the analyst average of $79.875, but this depends on the company executing its development plan without significant delays. Investors should monitor cash burn and regulatory milestones closely.
OKLO is significantly overvalued based on traditional metrics, with an EV/Sales of 4504.24 and negative PE ratios. The market is pricing in massive future growth, which is typical for pre-revenue companies but leaves little room for error. Compared to the industry average, the premium is extreme, but it may be justified if the company successfully commercializes its technology. The stock is trading near its 52-week low, which could indicate a value opportunity, but the lack of revenue makes it difficult to assess intrinsic value. Investors are paying for potential, not current performance.
OKLO is a high-risk, high-reward speculative stock. The average analyst target of $79.875 implies a 99% upside from the current price of $40.14, but the wide range (low $14, high $130) reflects extreme uncertainty. The company has zero revenue and a widening net loss of -$33.06 million in Q1 2026, making it unsuitable for conservative investors. However, for those with a high risk tolerance and a long-term horizon, the Meta deal and government support could lead to substantial gains. It is a good buy only if you can stomach significant volatility and potential losses of up to 65% in a bear case.
OKLO is more suitable for long-term investment, given its pre-revenue status and the long timeline to commercialization. The company's technology and partnerships could take 5-10 years to generate meaningful revenue, so short-term trading is highly speculative and subject to extreme volatility, as evidenced by the stock's 48.47% decline over the past year. The beta of 1.201 means the stock moves 20% more than the market, making it risky for short-term traders. For long-term investors, the potential for significant upside exists if the company succeeds, but they must be prepared for a bumpy ride. A minimum holding period of 5 years is recommended to allow the company to reach key milestones.